First targeted treatment to reduce the risk of ALK positive lung cancer returning after complete tumour removal recommended by NICE
For the first time, NICE has recommended a targeted treatment option for ALK-positive non-small-cell lung cancer, to be given after surgery to reduce the risk of the disease coming back.